Predicted protein targets (top 11)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.37 |
| ▸ | CA14 | Q9ULX7 | 3/20 | 0.34 |
| ▸ | TSHR | P16473 | 3/20 | 0.33 |
| ▸ | CA12 | O43570 | 2/20 | 0.32 |
| ▸ | HSD17B10 | Q99714 | 1/20 | 0.32 |
| ▸ | CA1 | P00915 | 1/20 | 0.31 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | ESRRB | O95718 | 1/20 | 0.31 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.31 |
| ▸ | CA7 | P43166 | 1/20 | 0.30 |
| ▸ | CA9 | Q16790 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL15910174 | 0.77 | SMN1; SMN2 (0.42) | SMN1; SMN2CA14TSHRCA12HSD17B10 | |
| SCHEMBL445678 | 0.77 | — | — | |
| SCHEMBL10125303 | 0.77 | — | — | |
| SCHEMBL14680929 | 0.77 | — | — | |
| SCHEMBL12135801 | 0.73 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14TSHRCA12HSD17B10 | |
| SCHEMBL3892276 | 0.73 | — | — | |
| SCHEMBL10272235 | 0.73 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14TSHRCA12HSD17B10 | |
| SCHEMBL13057735 | 0.73 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14TSHRCA12HSD17B10 | |
| SCHEMBL12135807 | 0.73 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14TSHRCA12HSD17B10 | |
| SCHEMBL445988 | 0.73 | SMN1; SMN2 (0.39) | SMN1; SMN2CA14TSHRCA12HSD17B10 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0413762-A4 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | — | 1992-01-15 | — | — | EP | disclosed |
| EP-0413762-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INCORPORATED (US) | 1991-02-27 | — | — | EP | disclosed |
| WO-1989010961-A1 | PEPTIDE ANALOGS AND THEIR USE AS HAPTENS TO ELICIT CATALYTIC ANTIBODIES | IGEN, INC. (US) | 1989-11-16 | — | — | WO | disclosed |